Intellia Thera CS(NTLA-Q)NASDAQ
Today's Change
Real-Time Last Update
Pre Market Change
Pre Market Last Update
Volume
Intellia Thera CS
40 Erie Street Suite 130Cambridge MA 02139 USA
P: 857-285-6200
http://www.intelliatx.com
Sectors & Indices
Sector
Industry
Employees
Profile
Intellia Therapeutics is a leading clinical-stage genome editing company focused on developing CRISPR/Cas9-based therapeutics. The company is pursuing two primary approaches to fully realize the transformative potential of CRISPR/Cas9 in vivo programs that use intravenously administered CRISPR as the therapy and ex vivo programs that use CRISPR to create the therapy by using engineered human cells.'
Key Executives
| Name | Title |
|---|---|
| Edward J. Dulac | CFO/Executive VP/Treasurer |